Skip to main content

BIIB Competitors

profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptionsprice historyeventsinsiders

Biogen Inc. News

Stock Market Today - 5/3: Stocks End Higher Amid Fed Rate Hike Bets; Treasury Yields Ease

Stocks finish higher Tuesday as the Federal Reserve begins its two-day policy meeting amid bets on faster and deeper near-term rate hikes.

Biogen Stock Gains After Q1 Earnings Miss; CEO Michel Vounatsos Exits

"I will be leaving at a time of promise for Biogen, with noteworthy potential for value creation," said departing CEO Michel Vounatsos.

Should Biogen Investors Be Worried About Its Alzheimer's Drug?

A Medicare policy decision might hurt sales of this biotech giant's Alzheimer's drug.

Biogen's ALS Drug Won't Move Forward After Trial Failures

Biogen will stop developing a drug to treat a severe neurodegenerative disease, as it did not show sufficient benefit when tested in trials.

Novartis and Roche Have Expensive Drugs That Scare Away Competitors

A brief snapshot of some medical breakthroughs that are among the costliest in the world.

Breaking News

Tesla Q2 Deliveries Slump To 254,695 As Shanghai Shutdown, Supply Chain Snarls Take Toll

Tesla said it had a record rate of production in June, but supply chain disruption and the closure of its Shanghai gigafactory triggered a slump in Q2 deliveries.

Roe v. Wade: Google Makes a Major Decision to Protect Privacy

Google will delete a person's location history for going to an abortion clinic.

Elon Musk Drops The Curtain On His Natures

The billionaire and CEO of Tesla remains an enigma despite its omnipresence on social media.

Coinbase Faces A New Scandal

The platform denies selling proprietary customer data and announces it is expanding into several European countries.